High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

Guardado en:
Detalles Bibliográficos
Autores principales: Rosmely Hernandez, Kathryn M LaPorte, Sunnie Hsiung, Alicia Santos Savio, Thomas R Malek
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/49472d5967644776960427a0c7300573
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:49472d5967644776960427a0c7300573
record_format dspace
spelling oai:doaj.org-article:49472d5967644776960427a0c73005732021-11-04T16:30:06ZHigh-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity10.1136/jitc-2021-0028652051-1426https://doaj.org/article/49472d5967644776960427a0c73005732021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e002865.fullhttps://doaj.org/toc/2051-1426Rosmely HernandezKathryn M LaPorteSunnie HsiungAlicia Santos SavioThomas R MalekBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Rosmely Hernandez
Kathryn M LaPorte
Sunnie Hsiung
Alicia Santos Savio
Thomas R Malek
High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
format article
author Rosmely Hernandez
Kathryn M LaPorte
Sunnie Hsiung
Alicia Santos Savio
Thomas R Malek
author_facet Rosmely Hernandez
Kathryn M LaPorte
Sunnie Hsiung
Alicia Santos Savio
Thomas R Malek
author_sort Rosmely Hernandez
title High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
title_short High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
title_full High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
title_fullStr High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
title_full_unstemmed High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
title_sort high-dose il-2/cd25 fusion protein amplifies vaccine-induced cd4+ and cd8+ neoantigen-specific t cells to promote antitumor immunity
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/49472d5967644776960427a0c7300573
work_keys_str_mv AT rosmelyhernandez highdoseil2cd25fusionproteinamplifiesvaccineinducedcd4andcd8neoantigenspecifictcellstopromoteantitumorimmunity
AT kathrynmlaporte highdoseil2cd25fusionproteinamplifiesvaccineinducedcd4andcd8neoantigenspecifictcellstopromoteantitumorimmunity
AT sunniehsiung highdoseil2cd25fusionproteinamplifiesvaccineinducedcd4andcd8neoantigenspecifictcellstopromoteantitumorimmunity
AT aliciasantossavio highdoseil2cd25fusionproteinamplifiesvaccineinducedcd4andcd8neoantigenspecifictcellstopromoteantitumorimmunity
AT thomasrmalek highdoseil2cd25fusionproteinamplifiesvaccineinducedcd4andcd8neoantigenspecifictcellstopromoteantitumorimmunity
_version_ 1718444646129991680

Ejemplares similares